Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM10 | O14672 | 15/20 | 0.56 |
| ▸ | ERBB2 | P04626 | 15/20 | 0.56 |
| ▸ | MMP2 | P08253 | 12/20 | 0.49 |
| ▸ | MMP9 | P14780 | 6/20 | 0.43 |
| ▸ | CTSB | P07858 | 2/20 | 0.40 |
| ▸ | CTSS | P25774 | 2/20 | 0.40 |
| ▸ | CTSK | P43235 | 2/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 4/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5621804 | 0.90 | ADAM10 (0.56) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL6024446 | 0.87 | ADAM10 (0.53) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL6024548 | 0.85 | ADAM10 (0.53) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL6025016 | 0.84 | ADAM10 (0.56) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL3457323 | 0.83 | ADAM10 (0.55) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL6025097 | 0.83 | ADAM10 (0.51) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL3458419 | 0.83 | ADAM10 (0.50) | ADAM10ERBB2MMP2MMP9SIGMAR1 | |
| SCHEMBL6024991 | 0.83 | ADAM10 (0.54) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL6024771 | 0.82 | ADAM10 (0.50) | ADAM10ERBB2MMP2MMP9CTSB | |
| SCHEMBL6024732 | 0.82 | ADAM10 (0.53) | ADAM10ERBB2MMP2MMP9CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2264030-A1 | Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases | Incyte Corporation (US) | 2010-12-22 | — | — | EP | claimed |
| JP-2007509075-A | — | — | 2007-04-12 | — | — | JP | claimed |
| EP-1678167-A1 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES | Incyte Corporation (US) | 2006-07-12 | — | — | EP | claimed |
| WO-2005037826-A1 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES | INCYTE CORPORATION (US) | 2005-04-28 | — | — | WO | claimed |
| EP-1678167-A1 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES | Incyte Corporation (US) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005037826-A1 | SUBSTITUTED CYCLIC HYDROXAMATES AS INHIBITORS OF MATRIX METALLOPROTEINASES | INCYTE CORPORATION (US) | 2005-04-28 | — | — | WO | disclosed |